Juvenile myasthenia gravis (JMG) is an acquired autoimmune condition of the neuromuscular junction, caused by an antibody-mediated attack on the nicotinic acetylcholine receptor (AChR) and in a small minority associated with muscle-specific kinase (MuSK) antibodies. To determine the clinical and evolution related features of JMG in a 240 argentinian pediatric cohort. Cross sectional study of patients with JMG at three argentinian hospital, from January 1993 to January 2018. We included 240 patients by the symptoms, electrophysiology, AChR or MuSK antibody levels and a positive response to pharmacological treatment.

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...